| Michael Steven Boulos, | |
|
90 Brick Rd Fl 3, Marlton, NJ 08053-2177 | |
| (856) 355-6000 | |
| (856) 355-6731 |
| Full Name | Michael Steven Boulos |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Location | 90 Brick Rd Fl 3, Marlton, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326608365 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 25MA11518400 (New Jersey) | Primary |
| 208M00000X | Hospitalist | MD478494 (Pennsylvania) | Secondary |
| Entity Name | Virtua Medical Group, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649226515 PECOS PAC ID: 9830222397 Enrollment ID: O20100804000338 |
News Archive
In rheumatoid arthritis, antibodies are formed that affect the inflammation in the joints. In an article published today in the journal Annals of the Rheumatic Diseases, researchers at Uppsala University show that antibodies against the cartilage protein collagen II are associated with a good prognosis.
The effects of obesity - both on our bodies and on the health budget - are well known, and now, scientists are getting closer to understanding how the disease progresses, providing clues for future treatments.
Idera Pharmaceuticals, Inc. today announced that it has chosen to delay initiating its planned Phase 2 clinical trial of IMO-2125 based on preliminary data from a 26-week nonclinical toxicology study of IMO-2125 in rodents. The Phase 2 clinical trial involves the evaluation of IMO-2125 plus ribavirin in treatment-naïve, genotype 1 hepatitis C virus (HCV) patients.
Older adults who added hazelnuts to their diet for a few months significantly improved their levels of two key micronutrients, new research at Oregon State University indicates.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Steven Boulos, 301 Lippincott Dr Ste 410, Marlton, NJ 08053-4197 Ph: (856) 355-6000 | Michael Steven Boulos, 90 Brick Rd Fl 3, Marlton, NJ 08053-2177 Ph: (856) 355-6000 |
News Archive
In rheumatoid arthritis, antibodies are formed that affect the inflammation in the joints. In an article published today in the journal Annals of the Rheumatic Diseases, researchers at Uppsala University show that antibodies against the cartilage protein collagen II are associated with a good prognosis.
The effects of obesity - both on our bodies and on the health budget - are well known, and now, scientists are getting closer to understanding how the disease progresses, providing clues for future treatments.
Idera Pharmaceuticals, Inc. today announced that it has chosen to delay initiating its planned Phase 2 clinical trial of IMO-2125 based on preliminary data from a 26-week nonclinical toxicology study of IMO-2125 in rodents. The Phase 2 clinical trial involves the evaluation of IMO-2125 plus ribavirin in treatment-naïve, genotype 1 hepatitis C virus (HCV) patients.
Older adults who added hazelnuts to their diet for a few months significantly improved their levels of two key micronutrients, new research at Oregon State University indicates.
› Verified 6 days ago
Marrian Sedrak, DO Hospitalist Medicare: Medicare Enrolled Practice Location: 90 Brick Rd Fl 3, Marlton, NJ 08053 Phone: 856-355-6000 | |
Shapour Steve Mirmanesh, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 12000 Lincoln Drive West, Suite 405, Marlton, NJ 08053 Phone: 856-985-0203 Fax: 856-985-0010 | |
Lucinda Fisher, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 90 Brick Rd Fl 3, Marlton, NJ 08053 Phone: 856-355-6000 Fax: 856-355-6731 |